Title : Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB - Nelson_2009_J.Alzheimers.Dis_16_29 |
Author(s) : Nelson PT , Kryscio RJ , Abner EL , Schmitt FA , Jicha GA , Mendiondo MS , Cooper G , Smith CB , Markesbery WR |
Ref : J Alzheimers Dis , 16 :29 , 2009 |
Abstract :
Dementia can be caused by different diseases including Alzheimer's disease (AD), dementia with Lewy bodies (DLB), or both (AD + DLB). University of Kentucky AD Center pathologically-diagnosed AD and AD + DLB cases were evaluated who had three or more longitudinal antemortem mental status examinations (n = 156). Patients with important concomitant pathology (n = 5) or patients that were profoundly demented at recruitment (intake MMSE < 20; n = 86) were excluded to strengthen our ability to test the association of specific clinical and pathological indices. Patients with pathologically-diagnosed AD + DLB (n = 25) lost cognitive capacity faster than patients with AD alone (n = 40). In both diseases, treatment with acetylcholinesterase inhibitors was associated with a slower rate of cognitive decline. |
PubMedSearch : Nelson_2009_J.Alzheimers.Dis_16_29 |
PubMedID: 19158418 |
Nelson PT, Kryscio RJ, Abner EL, Schmitt FA, Jicha GA, Mendiondo MS, Cooper G, Smith CB, Markesbery WR (2009)
Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB
J Alzheimers Dis
16 :29
Nelson PT, Kryscio RJ, Abner EL, Schmitt FA, Jicha GA, Mendiondo MS, Cooper G, Smith CB, Markesbery WR (2009)
J Alzheimers Dis
16 :29